M4MM

CRS Reveals Hemp Ban Enforcement Hurdles

WASHINGTON – The Congressional Research Service (CRS) has highlighted gaps in the federal government's plans to enforce the upcoming ban on intoxicating hemp products, raising questions about the practical reach of the law amid the ...

Planet 13 Reports Q3 2025 Financial Results

LAS VEGAS – Planet 13 Holdings Inc., a multistate Cannabis operator with flagship operations in Nevada and Florida, disclosed a $44 million net loss for the third quarter, reflecting the toll of compressed prices, softening ...

CRS Reveals Hemp Ban Enforcement Hurdles

WASHINGTON – The Congressional Research Service (CRS) has highlighted gaps in the federal government's plans to enforce the upcoming ban on intoxicating hemp products, raising questions about the practical reach of the law amid the ...

  • Fast Buds - German cannabis legalisation

German Medical Cannabis Market Sees Significant Growth

LOS ANGELES- Germany's medical cannabis industry is experiencing substantial growth, driven by recent regulatory reforms and increasing patient demand. Companies such as Cantourage are at the forefront of this expansion, capitalizing on the evolving legal ...

Silo Pharma Initiates Safety Study for PTSD Drug SPC-15

LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, has commenced a 7-day safety and toxicology study for its lead candidate, SPC-15, an intranasal treatment targeting post-traumatic stress disorder (PTSD). The study is being conducted ...

  • Village Farms International

Village Farms International Reports Q1 2025

LOS ANGELES- Village Farms International Inc. has announced its financial results for the first quarter of 2025, highlighting a strategic pivot towards its cannabis operations and the privatization of certain fresh produce assets. For the ...

Cybin Secures Additional U.S. Patent for CYB003

LOS ANGELES- Cybin Inc. a biopharmaceutical company, announced the granting of U.S. patent 12,291,499 by the United States Patent and Trademark Office. This patent pertains to pharmaceutical compositions and oral dosage forms within the company's ...

Subscribe To Our Newsletter